Targeted gene next-generation sequencing panel in patients with advanced lung adenocarcinoma: Paving the way for clinical implementation

Identification of targetable molecular changes is essential for selecting appropriate treatment in patients with advanced lung adenocarcinoma. Methods: In this study, a Sanger sequencing plus Fluorescence In Situ Hybridization (FISH) sequential approach was compared with a Next-Generation Sequencing...

Full description

Bibliographic Details
Main Author: Fernandes, MGO (author)
Other Authors: Jacob, M (author), Martins, N (author), Moura, CS (author), Guimarães, S (author), Reis, J (author), Justino, A (author), Pina, MJ (author), Cirnes, L (author), Sousa, C (author), Pinto, J (author), Marques, JA (author), Machado, JC (author), Hespanhol, V (author), Costa, JL (author)
Format: article
Language:eng
Published: 2019
Subjects:
Lung cancer
Molecular profiling
Next-generation sequencing
Targeted therapy
Online Access:https://hdl.handle.net/10216/136254
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/136254

Internet

https://hdl.handle.net/10216/136254

Similar Items